“IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS”, Mediterr J Hematol Infect Dis, vol. 1, no. 2, p. e2009010, Nov. 2009, doi: 10.4084/mjhid.2009.010.